Gapping up
In reaction to strong earnings/guidance:
- ASNA +16.8%, DSW +13.7%, ROAD +2.9%
Other news:
- NEOS +8.1% (CEO disclosed the purchase of ~17K shares)
- WPP +5.9% (expects to deliver organic growth in line with its peers)
- KNSA +4% (announces interim data from open-label Phase 2 clinical trial of rilonacept) GM +2.6% (China has reportedly decided to move forward with a reduction on auto tariffs on imported U.S.-made cars)
- F +2.6% (China has reportedly decided to move forward with a reduction on auto tariffs on imported U.S.-made cars)
- NOC +1.6% (following today's notable strength in defense names; also to change in pension accounting)
- MRK +1% (Merck appoints Michael Nally CMO, effective January 1)
- AAPL +1% (rebound continues)
- ITCI +1% (FDA has accepted for approval NDA regarding lumateperone)
Analyst comments:
- BCOV +3% (upgraded to Buy from Neutral at B. Riley FBR)
- NOK +2.5% (added to US 1 List at BofA/Merrill)
